-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

603. Lymphoid Oncogenesis: Basic: Poster III

Symposia: Lymphoid Oncogenesis: Basic Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Kohei Kume, PhD1*, Jaewoong Lee, PhD1,2*, Zhangliang Cheng1*, Mark E Robinson, PhD1*, Etienne Leveille, MD-PhD1*, Kadriye Nehir Cosgun, PhD1*, Lai N Chan, PhD1, Yanzhi Feng1*, David Fonseca Arce1*, Dhruv Khanduja1*, Derek Toomre, PhD3* and Markus Müschen, MD1

1Center of Molecular and Cellular Oncology, Yale University, New Haven, CT
2School of Biosystems and Biomedical Sciences, Korea University, Seoul, Korea, Republic of (South)
3Department of Cell Biology and Biophysics, Yale University, New Haven, CT

Julieta Sepulveda-Yanez, MSc1,2*, Diego Alvarez-Saravia3*, David Medina, PhD4*, Edwin Quinten, BS2*, Szymon M. Kiełbasa, PhD5*, Marcelo Navarrete, MD6, Cornelis A.M. van Bergen, PhD2* and Hendrik Veelken, MD, PhD 2

1Facultad de Ciencias de la Salud, Universidad de Magallanes, Punta Arenas, Chile
2Hematology, Leiden University Medical Center, Leiden, Netherlands
3Universidad de Magallanes, Punta Arenas, Chile
4Departamento de Ingenieria en Computacion, Universidad de Magallanes, Punta Arenas, Chile
5Biological Data Sciences, Leiden University Medical Center, Leiden, Netherlands
6Centro Asistencial Docente y de Investigacion, Universidad de Magallanes, Punta Arenas, Chile

Janek S. Walker, PhD1, Kerstin Wenzl, PhD2,3*, Joseph P. Novak2*, Michelle Manske, MS, BS1*, Makayla Serres2*, Allison M. Bock, MD4, Melissa A. Hopper, BS, MS1, Jordan Edward Krull1*, Abigail R. Dropik, BS1, Miranda S. Laverty5*, Vivekananda Sarangi1*, Matthew J. Maurer, DSc6, Lisa M. Rimsza, MD7, Brian K. Link, MD8*, Thomas M. Habermann, MD2, Rebecca L. King, MD9, Stephen M Ansell, MD, PhD2, Thomas E. Witzig, MD1, Grzegorz S. Nowakowski, MD2, James R. Cerhan, MD, PhD10 and Anne J. Novak, PhD1

1Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Rochester, MN
3Bristol Myers Squibb, Summit, NJ
4Division of Hematology and Medical Oncology, Mayo Clinic, Rochester
5Mayo Clinic, Rochester
6Department of Health Sciences Research, Mayo Clinic, Rochester, MN
7The University of Arizona Medical Center, Scottsdale, AZ
8Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
9Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
10Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN

Patryk Gorniak, PhD1*, Ondrej Havránek2,3, Anna Polak4* and Przemyslaw Juszczynski, MD, PhD5*

1Institute of Hematology and Transfusion Medicine, Warsaw, Poland
2First Dept. of Internal Medicine- Hematology, University General Hospital in Prague and First Faculty of Medicine, Charles University, Praha 2, Czech Republic
3First Faculty of Medicine, BIOCEV, Charles University, Vestec, Czech Republic
4Institute of Hematology and Transfusion Medicine, Warszawa, Ma, POL
5Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, POL

Patrizia Mondello, MD, PhD, MSc1, Prithviraj Mukherjee1*, Geoffrey Nelson2*, Surendra Dasari, PhD3*, Christine Hachfeld1*, Vaishali Bhardwaj, PhD1, Xinyi Tang1*, Zhi-Zhang Yang1*, Zhiquan Wang, PhD1, Megan Weivoda, PhD1, Mark Shlomchik4*, Laura Pasqualucci, MD5*, Karen Adelman2* and Stephen M Ansell, MD, PhD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Cambridge, MA
3Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
4Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA
5Institute for Cancer Genetics, Columbia University, New York, NY

Jean-Baptiste Alberge, PhD1, Ankit K. Dutta, PhD1*, Elizabeth D. Lightbody, PhD1, Andrea Poletti, PhD1*, Sofia Wallin1*, Andrew Dunford2*, Tim Coorens, PhD2*, Xavi Loinaz2*, Cody J. Boehner, BSc1*, Nang Kham Su, MSc1*, Laura Hevenor, BS1*, Katherine Towle, BS1*, Jacqueline Perry, MPH1*, Kirsten Kübler, MD2*, Romanos Sklavenitis-Pistofidis, MD1, Julian Hess2*, Chip Stewart, PhD2*, Gad Getz, PhD2* and Irene M. Ghobrial, MD1

1Dana-Farber Cancer Institute, Boston, MA
2Broad Institute of MIT and Harvard, Cambridge, MA

Milad Razavi-Mohseni, Dustin Shigaki* and Michael A Beer*

Department of Biomedical Engineering and McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University, Baltimore, MD

Julian Tobon, BS1,2*, Pawel Nowialis, PhD1,2,3*, Katarina Lopusna, PhD1,2,4*, Duo Chen, MS1,2*, Arshee Badar, MD1,2*, Reem Abdelghany5*, Emma Noel6*, Jacob Fingeret5*, Gene Pozas5*, Jana Opavska, MS1,2*, Hiroshi Fujiwara, MD, PhD7 and Rene Opavsky, PhD1,2

1Department of Anatomy and Cell Biology, University of Florida, Gainesville, FL
2UF NCI-designated Cancer Center, University of Florida, Gainesville, FL
3Department of Molecular Medicine, University of Texas Health Science Center, San Antonio, TX
4Department of Microbiology and Virology, Comenius University, Bratislava, Slovakia
5UF College of Liberal Arts and Sciences, University of Florida, Gainesville, FL
6College of Agriculture and Life Sciences, University of Florida, Gainesville, FL
7Ehime University, School of Medicine, Tsu, MIE, JPN

Xiangrong Geng1*, Chenguang Wang1*, Ashley Wolfe1*, Ira Maine1*, Suhaib Abdelrahman1*, Carlos A. Murga-Zamalloa, MD2 and Ryan A. Wilcox, MD3

1University of Michigan, Ann Arbor, MI
2University of Illinois Chicago, Chicago, IL
3Division of Hematology/Oncology, University of Michigan Cancer Center, Ann Arbor, MI

Maria D Rivera, MS1*, Jessica Pham2*, Jane Isquith, BS, MS1*, Haoran Zhang, BS1*, Jenny Zhou2*, Roman Sasik1*, Adam Mark3*, Wenxue Ma, MD, PhD2*, Frida Holm, PhD4*, Kathleen Fisch3*, Dennis John Kuo, MD, MS5*, Catriona Jamieson, MD, PhD6 and Qingfei Jiang, PhD7

1University of California, San Diego, La Jolla, CA
2University of California San Diego, La Jolla, CA
3Center for Computational Biology and Bioinformatics, UCSD, La Jolla, CA
4Karolinska Institutet, Solna, Sweden
5Rady Children's Hospital, University of California San Diego, San Diego, CA
6Division of Regenerative Medicine, Department of Medicine, and Sanford Stem Cell Institute, UCSD, La Jolla, CA
7UCSD, La Jolla, CA

Ye Xin1*, Xiaowen Chen2*, Mengli Zhang1*, Yingcai Jin1*, Jinchao Xu1*, Jianxiang Zhang1*, Xinfeng Chen1*, Xue Yang1*, Madeline Niederkorn, PhD3, Feiqiu Wen2* and Peng Xu, PhD4

1Soochow University, Suzhou, China
2Shenzhen Children's Hospital, shenzhen, China
3St. Jude Children's Research Hospital, Memphis, TN
4Hematology Center, Cyrus Tang Medical Institute, Soochow University, SUZHOU, CHN

Maximilian Schinke, PhD1*, Marc-Jens Kleppa, PhD1*, Dirk Heckl, PhD2,3*, Michael Heuser, MD4, Axel Schambach, MD, PhD5* and Adrian Schwarzer, MD, PhD4,6,7

1Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany
2Department of Pediatric Hematology and Oncology, Martin‐Luther‐University Halle‐Wittenberg, Halle, Germany
3Institute for Experimental Pediatric Hematology and Oncology, Goethe University Frankfurt, Frankfurt, Germany
4Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
5Institute of Experimental Hematology, Hannover Medical School, Hannover, DEU
6Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany
7Institute of Experimental Hematology, Hannover Medical School, Hannover, Lower Saxony, Germany

Xiaolin Lai, MD, PhD1,2*, Yuanhua Cai, MD, PhD1,2*, Yuanmao Huang, MD, PhD1,2*, Shuiling Shi, MD1,2*, Zhixiang Chen, MD1,2*, Xuechun Wang, PhD1,3*, Fuquan Tu, MD, PhD1,2,4*, Luya Ye, MD1,2*, Xiaofan Li, MD, PhD1,2, Lili PAN, MD, PhD1,2*, Jinggang Li, MD, PhD1,2*, Yang Li, MD, PhD1,2*, Huiying Gao, MD1,2* and Shaoyuan Wang, MD1,2*

1Union Clinical Medical Colleges, Fujian Medical University, Fuzhou, China
2Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, China
3Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, NJ, China
4Emergency Intensive Care Unit, Fujian Medical University Union Hospital, Fuzhou, China

Larissa Helena Moura-Castro, MSc1*, Minjun Yang1*, Eleanor Woodward, PhD1*, Anders Castor2*, Thoas Fioretos, MD, PhD1, Bertil Johansson1,3*, Marcus Järås, PhD4*, Anna Hagström, PhD5* and Kajsa Paulsson1

1Department of Clinical Genetics, Lund University, Lund, Sweden
2Childhood Cancer Center, Skåne University Hospital, Lund, Sweden
3Department of Clinical Genetics, Pathology, and Molecular Diagnostics, Region Skåne, Lund, Sweden
4Division of Clinical Genetics, Lund University, Lund, Skåne, Sweden
5Department of Laboratory Medicine, Division of Clinical Genetics, Lund University, Lund, Sweden

*signifies non-member of ASH